About the Kit...

This volume focuses on eight important trials currently in progress. Four of these studies (ACCORD, BAR.I 2D, VADT, and Look AHEAD) explore outcomes of various therapeutic regimens on cardiovascular morbidity, and mortality in established T2DM. The other four studies (ORIGIN, NAVIGATOR, DREAM, and ADOPT) evaluate whether aggressive treatment options can delay the onset and/or progression of pre-diabetes or early T2DM and the effects on cardiovascular risk factors. ORIGIN and NAVIGATOR are sufficiently powered to give us definitive answers on hard outcomes on cardiovascular events. Over the next 5 to 10 years, these research outcomes will likely change the face of T2DM.

To view the slides and notes on-line, click here.